 Dong Wang
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 2 | 2022 | 177 | 0.760 |
Why?
| | Medulloblastoma | 2 | 2022 | 215 | 0.740 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.530 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.530 |
Why?
| | Glucosides | 1 | 2018 | 55 | 0.530 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 82 | 0.510 |
Why?
| | Kidney Diseases | 2 | 2018 | 427 | 0.490 |
Why?
| | Bile Acids and Salts | 5 | 2020 | 164 | 0.460 |
Why?
| | Liver Diseases | 1 | 2018 | 304 | 0.430 |
Why?
| | Acinar Cells | 5 | 2014 | 13 | 0.420 |
Why?
| | Heart | 1 | 2017 | 636 | 0.400 |
Why?
| | Glioma | 4 | 2022 | 425 | 0.390 |
Why?
| | Kidney | 2 | 2017 | 1495 | 0.370 |
Why?
| | Myocardium | 1 | 2017 | 939 | 0.360 |
Why?
| | Zinc Fingers | 2 | 2009 | 53 | 0.340 |
Why?
| | Genome, Plant | 2 | 2008 | 34 | 0.340 |
Why?
| | Oryza | 2 | 2008 | 32 | 0.340 |
Why?
| | Pancreas | 4 | 2014 | 341 | 0.320 |
Why?
| | Arabidopsis | 2 | 2008 | 95 | 0.320 |
Why?
| | Hypertension | 1 | 2017 | 1263 | 0.280 |
Why?
| | Diet, Western | 2 | 2020 | 86 | 0.280 |
Why?
| | Biliary Atresia | 2 | 2021 | 158 | 0.270 |
Why?
| | Obesity | 2 | 2018 | 3077 | 0.260 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 209 | 0.230 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2017 | 233 | 0.220 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 3540 | 0.200 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 318 | 0.200 |
Why?
| | Brain Stem Neoplasms | 2 | 2021 | 87 | 0.200 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2014 | 72 | 0.190 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.180 |
Why?
| | Cell Proliferation | 4 | 2022 | 2496 | 0.180 |
Why?
| | Liver | 3 | 2020 | 1887 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 66 | 0.170 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2021 | 20 | 0.170 |
Why?
| | Radiation Tolerance | 1 | 2022 | 103 | 0.170 |
Why?
| | Receptor, trkC | 1 | 2021 | 10 | 0.170 |
Why?
| | Pancreatitis | 2 | 2012 | 145 | 0.170 |
Why?
| | Receptor, trkB | 1 | 2021 | 36 | 0.170 |
Why?
| | Rhabdoid Tumor | 1 | 2022 | 103 | 0.160 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 64 | 0.160 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 66 | 0.160 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 39 | 0.160 |
Why?
| | Immunoglobulin M | 1 | 2021 | 284 | 0.150 |
Why?
| | Piperazines | 1 | 2022 | 381 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 198 | 0.150 |
Why?
| | Apoptosis | 3 | 2022 | 2430 | 0.150 |
Why?
| | Taurolithocholic Acid | 3 | 2014 | 3 | 0.140 |
Why?
| | DNA Repair | 1 | 2021 | 256 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 623 | 0.140 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 496 | 0.140 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.140 |
Why?
| | Aging | 2 | 2020 | 1966 | 0.140 |
Why?
| | Pyrazoles | 1 | 2022 | 509 | 0.140 |
Why?
| | Mice, Obese | 1 | 2018 | 66 | 0.130 |
Why?
| | Plant Proteins | 2 | 2009 | 112 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 628 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 529 | 0.130 |
Why?
| | Animals | 14 | 2022 | 38058 | 0.130 |
Why?
| | Histones | 2 | 2020 | 669 | 0.130 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.130 |
Why?
| | Urinalysis | 1 | 2017 | 80 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2020 | 527 | 0.130 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 128 | 0.130 |
Why?
| | Kidney Function Tests | 1 | 2017 | 157 | 0.130 |
Why?
| | Kidney Tubules | 1 | 2017 | 117 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 266 | 0.120 |
Why?
| | Calcium Signaling | 3 | 2013 | 251 | 0.120 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 288 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2017 | 168 | 0.110 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5992 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 338 | 0.100 |
Why?
| | Genes, Plant | 3 | 2009 | 46 | 0.100 |
Why?
| | Oxidative Stress | 2 | 2018 | 1339 | 0.100 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1370 | 0.100 |
Why?
| | Electrocardiography | 1 | 2017 | 662 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2022 | 2194 | 0.100 |
Why?
| | Mice | 11 | 2022 | 18339 | 0.100 |
Why?
| | Weight Gain | 1 | 2018 | 556 | 0.100 |
Why?
| | Autoantibodies | 1 | 2021 | 1501 | 0.100 |
Why?
| | Cytological Techniques | 1 | 2013 | 28 | 0.100 |
Why?
| | Adenoviridae Infections | 1 | 2013 | 20 | 0.100 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2012 | 28 | 0.100 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.090 |
Why?
| | Mutation | 2 | 2021 | 4089 | 0.090 |
Why?
| | Lipids | 1 | 2018 | 710 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2018 | 876 | 0.090 |
Why?
| | Calcineurin | 1 | 2012 | 105 | 0.090 |
Why?
| | Cytosol | 1 | 2012 | 227 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1769 | 0.080 |
Why?
| | Cytokines | 1 | 2018 | 2061 | 0.080 |
Why?
| | Calcium | 2 | 2014 | 1183 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 114 | 0.080 |
Why?
| | Gossypium | 1 | 2009 | 1 | 0.080 |
Why?
| | Inflammation | 2 | 2018 | 2878 | 0.070 |
Why?
| | Insulin Resistance | 1 | 2018 | 1241 | 0.070 |
Why?
| | Child | 4 | 2022 | 22633 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2008 | 65 | 0.070 |
Why?
| | Rats | 1 | 2017 | 5597 | 0.070 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2009 | 78 | 0.070 |
Why?
| | Chromosomes, Plant | 1 | 2008 | 10 | 0.070 |
Why?
| | RNA, Plant | 1 | 2008 | 10 | 0.070 |
Why?
| | Gene Duplication | 1 | 2008 | 67 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 851 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 224 | 0.060 |
Why?
| | Blood Glucose | 1 | 2018 | 2327 | 0.060 |
Why?
| | Multigene Family | 1 | 2008 | 204 | 0.060 |
Why?
| | Sequence Alignment | 1 | 2008 | 366 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 396 | 0.060 |
Why?
| | Arabidopsis Proteins | 1 | 2008 | 76 | 0.060 |
Why?
| | Humans | 13 | 2022 | 144759 | 0.060 |
Why?
| | DNA Primers | 1 | 2008 | 512 | 0.060 |
Why?
| | Cholesterol | 2 | 2020 | 406 | 0.060 |
Why?
| | Phylogeny | 2 | 2008 | 1016 | 0.060 |
Why?
| | Podocytes | 2 | 2017 | 80 | 0.060 |
Why?
| | Species Specificity | 1 | 2008 | 574 | 0.060 |
Why?
| | Chromatin | 2 | 2020 | 561 | 0.060 |
Why?
| | Male | 9 | 2021 | 72315 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4271 | 0.060 |
Why?
| | Signal Transduction | 2 | 2017 | 5226 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 453 | 0.060 |
Why?
| | Child, Preschool | 4 | 2021 | 11787 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2009 | 737 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1137 | 0.050 |
Why?
| | Base Sequence | 1 | 2008 | 2190 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1490 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2017 | 2832 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 2155 | 0.050 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 462 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2008 | 514 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2014 | 115 | 0.050 |
Why?
| | Ryanodine | 2 | 2014 | 15 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2930 | 0.050 |
Why?
| | Software | 1 | 2008 | 690 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2014 | 402 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 87 | 0.040 |
Why?
| | Disease Progression | 2 | 2021 | 2847 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1782 | 0.040 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 43 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 240 | 0.040 |
Why?
| | Teratoma | 1 | 2022 | 120 | 0.040 |
Why?
| | Mitochondria | 2 | 2017 | 984 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 370 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 307 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 28 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 37 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 279 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1837 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 129 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 167 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 115 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 621 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 2 | 2009 | 57 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4557 | 0.030 |
Why?
| | Lysine | 1 | 2020 | 302 | 0.030 |
Why?
| | Sulfonamides | 1 | 2022 | 580 | 0.030 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 12 | 0.030 |
Why?
| | Cholic Acids | 1 | 2017 | 13 | 0.030 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 21 | 0.030 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 187 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 479 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 169 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 29 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 299 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 88 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 190 | 0.030 |
Why?
| | Feces | 1 | 2020 | 513 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 508 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 127 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.030 |
Why?
| | Longevity | 1 | 2017 | 173 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 902 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 375 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1253 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2882 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 520 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 548 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 684 | 0.030 |
Why?
| | Carbachol | 1 | 2014 | 17 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1173 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 509 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1716 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1455 | 0.030 |
Why?
| | Ceruletide | 1 | 2012 | 4 | 0.020 |
Why?
| | Amylases | 1 | 2012 | 18 | 0.020 |
Why?
| | Egtazic Acid | 1 | 2012 | 38 | 0.020 |
Why?
| | Chymotrypsin | 1 | 2012 | 23 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2020 | 2050 | 0.020 |
Why?
| | Cell Death | 1 | 2014 | 383 | 0.020 |
Why?
| | Adenoviridae | 1 | 2013 | 199 | 0.020 |
Why?
| | Dantrolene | 1 | 2012 | 5 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 93 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 905 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2925 | 0.020 |
Why?
| | Cell Polarity | 1 | 2012 | 137 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 771 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4564 | 0.020 |
Why?
| | Tacrolimus | 1 | 2012 | 196 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2020 | 1318 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4154 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2009 | 15 | 0.020 |
Why?
| | Salicylic Acid | 1 | 2009 | 10 | 0.020 |
Why?
| | Droughts | 1 | 2009 | 32 | 0.020 |
Why?
| | Plant Diseases | 1 | 2009 | 44 | 0.020 |
Why?
| | Dehydration | 1 | 2009 | 56 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2008 | 15 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 661 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 126 | 0.020 |
Why?
| | Female | 3 | 2021 | 78271 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2933 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10034 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 618 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2583 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7173 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22428 | 0.010 |
Why?
|
|
Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|